| Primary |
| Hepatitis C |
53.2% |
| Chronic Hepatitis C |
11.2% |
| Prophylaxis |
7.4% |
| Product Used For Unknown Indication |
6.1% |
| Hypertension |
2.9% |
| Anaemia Prophylaxis |
2.5% |
| Hyperlipidaemia |
2.4% |
| Thrombocytopenia |
2.0% |
| Insomnia |
1.8% |
| Depression |
1.7% |
| Iron Deficiency Anaemia |
1.2% |
| Vitamin Supplementation |
1.1% |
| Arthralgia |
0.9% |
| Constipation |
0.9% |
| Dyspnoea |
0.8% |
| Hiv Infection |
0.8% |
| Diabetes Mellitus |
0.8% |
| Maternal Exposure During Pregnancy |
0.8% |
| Pyrexia |
0.8% |
| Nausea |
0.7% |
|
| Anaemia |
13.5% |
| Rash |
11.3% |
| Vomiting |
8.4% |
| Liver Function Test Abnormal |
7.6% |
| Hepatic Enzyme Increased |
6.9% |
| White Blood Cell Count Decreased |
5.5% |
| Weight Decreased |
4.4% |
| Decreased Appetite |
4.0% |
| Platelet Count Decreased |
4.0% |
| Pyrexia |
4.0% |
| Renal Impairment |
3.6% |
| Haemoglobin Decreased |
3.3% |
| Pancreatitis |
3.3% |
| Renal Disorder |
3.3% |
| Renal Failure Acute |
3.3% |
| Thrombocytopenia |
3.3% |
| Nausea |
2.9% |
| Drug Eruption |
2.5% |
| Pneumonia |
2.5% |
| Pruritus |
2.5% |
|
| Secondary |
| Chronic Hepatitis C |
48.6% |
| Hepatitis C |
33.3% |
| Hiv Infection |
3.7% |
| Prophylaxis |
3.0% |
| Product Used For Unknown Indication |
2.5% |
| Hypertension |
1.7% |
| Hyperlipidaemia |
1.1% |
| Adverse Event |
1.0% |
| Insomnia |
0.8% |
| Pyrexia |
0.7% |
| Arthralgia |
0.4% |
| Iron Deficiency Anaemia |
0.4% |
| Depression |
0.4% |
| Urticaria |
0.4% |
| Hyperuricaemia |
0.4% |
| Diabetes Mellitus |
0.4% |
| Pain |
0.3% |
| Nausea |
0.3% |
| Rash |
0.3% |
| Gastritis Prophylaxis |
0.3% |
|
| White Blood Cell Count Decreased |
23.7% |
| Neutrophil Count Decreased |
17.1% |
| Rash |
10.3% |
| Retinopathy |
7.3% |
| Renal Impairment |
4.3% |
| Platelet Count Decreased |
4.1% |
| Vomiting |
3.8% |
| Anaemia |
3.7% |
| Renal Disorder |
3.5% |
| Decreased Appetite |
3.1% |
| Haemoglobin Decreased |
2.9% |
| Malaise |
1.9% |
| Nausea |
1.9% |
| Retinal Haemorrhage |
1.9% |
| Thrombocytopenia |
1.9% |
| Erythema Multiforme |
1.9% |
| Neutropenia |
1.8% |
| Weight Decreased |
1.7% |
| Depression |
1.6% |
| Erythema |
1.5% |
|
| Concomitant |
| Hepatitis C |
86.2% |
| Chronic Hepatitis C |
7.5% |
| Hiv Infection |
2.6% |
| Product Used For Unknown Indication |
0.9% |
| Drug Use For Unknown Indication |
0.5% |
| Chronic Obstructive Pulmonary Disease |
0.3% |
| Anaemia |
0.3% |
| Pain |
0.2% |
| Hypertension |
0.2% |
| Menopausal Symptoms |
0.2% |
| Prophylaxis |
0.2% |
| Nausea |
0.1% |
| Depression |
0.1% |
| Adverse Event |
0.1% |
| Dependence |
0.1% |
| Multiple Myeloma |
0.1% |
| Abdominal Discomfort |
0.1% |
| Candidiasis |
0.1% |
| Factor Ix Deficiency |
0.1% |
| Nephrotic Syndrome |
0.1% |
|
| Rash |
13.3% |
| White Blood Cell Count Decreased |
12.2% |
| Neutrophil Count Decreased |
10.8% |
| Anaemia |
9.5% |
| Renal Impairment |
7.5% |
| Decreased Appetite |
6.7% |
| Haemoglobin Decreased |
5.6% |
| Drug Eruption |
4.8% |
| Platelet Count Decreased |
4.2% |
| Blood Creatinine Increased |
3.4% |
| Malaise |
3.1% |
| Erythema Multiforme |
2.7% |
| Renal Disorder |
2.6% |
| Retinopathy |
2.3% |
| Nausea |
2.2% |
| Hyperuricaemia |
2.2% |
| Depression |
1.9% |
| Loss Of Consciousness |
1.8% |
| Erythema |
1.7% |
| Blood Uric Acid Increased |
1.6% |
|
| Interacting |
| Hepatitis C |
80.0% |
| Hiv Infection |
20.0% |
|
|
